Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors

J Vasc Interv Radiol. 2023 Sep;34(9):1538-1546. doi: 10.1016/j.jvir.2023.05.012. Epub 2023 May 12.

Abstract

Purpose: To determine the risk factors for local of adult patients treated for desmoid tumors by cryoablation.

Materials and methods: Eighty-four patients treated for nonabdominopelvic desmoid tumors by cryoablation from July 2012 to July 2020 were included in a retrospective study. The population was composed of 64 women (76.19%) and 20 men (23.81%), aged from 16 to 75 years (median, 35 years ± 14.25). Each patient underwent preprocedural gadolinium-enhanced magnetic resonance imaging and was followed up to 36 months with the same technique. Clinical features, such as tumor size and previous treatment, epidemiological features, and the technical parameters of cryoablation, were studied.

Results: Local relapse was found in 19 (22.62%) of 84 patients. The 12-, 24-, and 36-month progression-free survival rates were 89% (95% confidence interval [CI], 79-94), 74% (95% CI, 60-83), and 68% (95% CI, 53-79), respectively. In univariate analysis, significant prognostic factors associated with local recurrence were non-abdominal wall location (P = .042), debulking strategy (P = .0105), risk of visceral injury (P = .034) or peripheral nerve injury during cryoablation (P = .033), previous radiation therapy (P = .043), and treatment before 2016 (P = .008). In multivariate analysis, abdominal wall tumors displayed the best outcome, whereas the neck and trunk showed a high rate of recurrence (hazard ratio, 7.307 [95% CI, 1.396-38.261]).

Conclusions: The local recurrence of desmoid tumors after cryoablation depends on a number of prognostic factors, in particular, a non-abdominal wall location of the tumor and previous local treatment such as surgery or radiation therapy.

MeSH terms

  • Adult
  • Cryosurgery* / adverse effects
  • Cryosurgery* / methods
  • Female
  • Fibromatosis, Aggressive* / diagnostic imaging
  • Fibromatosis, Aggressive* / pathology
  • Fibromatosis, Aggressive* / surgery
  • Humans
  • Male
  • Neoplasm Recurrence, Local / surgery
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome